Search

Search results

20 results found

BIDMC Resource Reminder!

The Biomarker & Metabolism Core provides access to Agilent Seahorse XFe analyzer, which measures and reports the oxygen consumption rate (OCR), proton efflux rate (PER) or extracellular acidification rate (ECAR), as well as ATP production rates of live cells in a 96-well format. OCR, PER, and ATP...

How to Cite and Acknowledge BIDMC Research Cores (RRIDs)

To ensure consistent recognition and support for BIDMC research cores, please use the following Research Resource Identifiers (RRIDs) when citing core facilities in your publications and grant applications. RRIDs provide a standardized way to acknowledge the contributions of shared resources...

Agilent Seahorse FLEX Analyzer for 3D Analysis on CLS5!  Come learn more!

The Joslin Diabetes DRC Molecular Phenotyping and Genotyping Core is excited to announce the installation of Agilent’s Seahorse XF Flex Analyzer as a self-service instrument for researchers. This instrument allows analysis of 3D samples such as tissue slices and organoids! To introduce the...

New Core Collaboration: Flow Cytometry-MassNano & Precision RNA Medicine

We are pleased to announce a new collaboration between the Flow Cytometry-MassNano Facility and the Precision RNA Medicine Core at BIDMC. This partnership integrates advanced nanoparticle characterization capabilities with lipid nanoparticle (LNP) formulation and production expertise, enabling...

Core Facilities

BIDMC Research Core Facilities, Core Facilities at BIDMC, we provide BIDMC researchers and external institutions with access to advanced technologies, specialized equipment, and expert guidance to accelerate scientific discovery.

Spatial Technologies Unit (STU) Named G4X Center of Excellence

We are pleased to share that the Spatial Technologies Unit (STU) at BIDMC has been designated as the first G4X™ Center of Excellence worldwide by Singular Genomics. This recognition reflects STU’s leadership in advancing spatial biology, including the successful validation of G4X assays across...